SAM

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	15

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 10 of 15 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05370079 (ClinicalTrials.gov)	September 16, 2022	6/5/2022	Control Cohort CTRL COH	Control Cohort CTRL COH	Parkinson's Disease; Amyotrophic Lateral Sclerosis; Glioblastoma; Cancer Without Neurological Diseas ...	Biological: Collection of biological sample (blood and/or CSF)	Hospices Civils de Lyon	NULL	Not yet recruiting	18 Years	N/A	All	350	N/A	France
2	NCT05699161 (ClinicalTrials.gov)	October 14, 2021	7/12/2022	Adipose-derived Stromal Vascular Fraction Cells to Treat Parkinson	Treatment of Parkinson Disease With Transplantation of SVF Cells of Adipose Origin: Safety and Explo ...	Idiopathic Parkinson Disease;Parkinson's Disease and Parkinsonism	Genetic: Adipose-derived stromal vascular fraction cells	Samuel Vilchez, PhD	Wake Forest University;Ministerio de Salud, Nicaragua;GID BIO, Inc.;National Autonomous University o ...	Completed	18 Years	80 Years	All	10	Phase 1/Phase 2	Nicaragua
3	NCT03947216 (ClinicalTrials.gov)	October 23, 2020	7/5/2019	Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5 ...	Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease ...	Parkinson Disease	Drug: Active drug: pimavanserin 17mg (2 strength tablets);Drug: Placebo: 2 tablets containing same e ...	University Hospital, Strasbourg, France	NS-PARK;EUCLID Clinical Trial Platform;F-CRIN	Recruiting	35 Years	75 Years	All	130	Phase 2	France
4	NCT04477161 (ClinicalTrials.gov)	September 5, 2019	22/6/2020	Effect of Ketone Esters in Parkinson's Disease	Effect of Ketone Esters on Parkinson Disease: A Pilot, Prospective Trial.	Parkinson Disease;Ketosis	Dietary Supplement: Ketone Ester Elite endurance Nutrition Drink;Other: Stool Sample	University of Florida	NULL	Completed	40 Years	75 Years	All	10	N/A	United States
5	ChiCTR1800019216	2017-09-30	2018-10-31	Study for accurate diagnosis and treatment of Parkinson's disease by using the combination of TMS-EE ...	Study for accurate diagnosis and treatment of Parkinson's disease by using the combination of TMS-EE ...	Parkinson's disease	Bradykinesia Group:Sick side, SAMregion, 10Hz rTMS;Tremor Group:Sick side, M1 region, 1Hz rTMS;Healt ...	Shenzhen People's Hospital	NULL	Recruiting	50	80	Both	Bradykinesia Group:30;Tremor Group:30;Health control:30;		China
6	JPRN-UMIN000022022	2016/05/10	10/05/2016	A randomized controlled study comparing lubiprostone and magnesium oxide for treatment of chronic co ...	A randomized controlled study comparing lubiprostone and magnesium oxide for treatment of chronic co ...	Parkinson diseaseChronic constipation	Study drug group: A 12-week administration of lubiprostone 24 microrgrum (adjustable) twice daily af ...	Dokkyo Medical University	NULL	Complete: follow-up complete	20years-old	90years-old	Male and Female	64	Not selected	Japan
7	JPRN-UMIN000022023	2016/05/10	10/05/2016	A randomized controlled study comparing lubiprostone and magnesium oxide for treatment of chronic co ...	A randomized controlled study comparing lubiprostone and magnesium oxide for treatment of chronic co ...	Parkinson diseaseChronic constipation	Study drug group: A 12-week administration of lubiprostone 24 microgrum (adjustable) twice daily aft ...	Dokkyo Medical University	NULL	Complete: follow-up complete	20years-old	90years-old	Male and Female	64	Not selected	Japan
8	NCT02775591 (ClinicalTrials.gov)	April 2016	9/5/2016	Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastro ...	Effect of Short-term Motilitone Therapy on Health-related Quality of Life in Parkinson's Disease Pat ...	Parkinson Disease;Dyspepsia	Drug: DA-9701;Drug: DA-9701 placebo	Seoul National University Hospital	Samsung Medical Center;Korea University Guro Hospital;Hanyang University;Seoul Veterans Hospital;SMG ...	Completed	50 Years	80 Years	All	147	Phase 4	Korea, Republic of
9	NCT02769793 (ClinicalTrials.gov)	June 2015	9/5/2016	Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in PD Patients With Del ...	Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in Parkinson's Disease ...	Parkinson Disease	Drug: Levodopa dispersible;Drug: Levodopa	Seoul National University Hospital	SMG-SNU Boramae Medical Center;Samsung Medical Center	Completed	31 Years	80 Years	All	40	Phase 4	Korea, Republic of
10	JPRN-UMIN000046104	2013/03/01	21/11/2021	Research for the development of assessment strategy and treatment for cognitive impairment of Parkin ...	Neuroimaging study for the assessment and treatment of cognitive impairment of the patients with Par ...	Parkinson's disease	This study followed a randomized double-blind crossover design for the patients with mild cognitive ...	Nagoya City University	NULL	Complete: follow-up complete	60years-old	75years-old	Male and Female	12	Not applicable	Japan

First Previous1 2Next Last